| Dr Jerry Steven Wong, PHARMD | |
|
1107 Gables Dr, Birmingham, AL 35244-2852 | |
| (205) 733-1597 | |
| Not Available |
| Full Name | Dr Jerry Steven Wong |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1107 Gables Dr, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134334642 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14067 (Alabama) | Primary |
| 183500000X | Pharmacist | PS35145 (Florida) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jerry Steven Wong, PHARMD 1107 Gables Dr, Birmingham, AL 35244-2852 Ph: () - | Dr Jerry Steven Wong, PHARMD 1107 Gables Dr, Birmingham, AL 35244-2852 Ph: (205) 733-1597 |
News Archive
Just two weeks without much activity can have a dramatic impact on health from which it is difficult to recover, according to researchers who studied overweight older adults at risk of developing Type 2 diabetes.
ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.
Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.
All patients with hepatitis C who receive a liver transplant will eventually infect their new livers. These transplanted organs then require anti-viral treatment before they become severely damaged. But traditional post-transplant hepatitis C therapy can take up to a year, is potentially toxic and can lead to organ rejection.
Sepsis is an inflammatory response to infection that's known to develop in hospital settings and can turn deadly when it's not discovered early on. In a new study, a hospital surveillance program focusing on reducing the risks of sepsis, known as the two-stage Clinical Decision Support (CDS) system, was found to reduce the risk of adverse outcomes, such as death and hospice discharge for sepsis patients, by 30% over the course of one year.
› Verified 9 days ago
Katerina Elaine Pappas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4616 Highway 280, Birmingham, AL 35242 Phone: 205-991-6248 | |
Lindsey Elmore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Lakeshore Dr, Birmingham, AL 35229 Phone: 205-726-4431 | |
Ms. Debra Mcconnell Larussa, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 Center Point Pkwy, Birmingham, AL 35215 Phone: 205-852-8001 Fax: 205-852-6879 | |
Dr. Joshua James Tessin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5350 | |
James Andrew Carr, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 19th Street South, Birmingham, AL 35233 Phone: 205-933-8101 Fax: 205-558-4784 | |
Betty A Morris, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5511 Highway 280, Suite 301, Birmingham, AL 35242 Phone: 205-995-8388 Fax: 205-995-8897 | |
Leanne Phillips, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Medical Park Dr E, Birmingham, AL 35235 Phone: 205-915-1011 |